期刊文献+

三臂非劣效性设计生存时间数据的半参数统计推断方法

Semiparametric Analyses of Three-arm Non-inferiority Trials for Censored Time-to-event Data
下载PDF
导出
摘要 目的推荐并改进一种用于新药临床试验中生存分析三臂非劣效性设计的半参数统计推断方法。方法采用Cox比例风险模型建立用于生存时间数据的三臂非劣效检验方法,通过模拟试验验证该方法的有效性,并给出样本含量估计的R语言程序。结果模拟试验结果证实,在样本删失风险率维持在一定水平时,三臂Cox模型能有效地控制I类错误发生概率,并保证较高的检验效能,实际应用简单有效。结论本文推荐的方法,可以有效地应用于三臂生存时间数据的非劣效性研究。 Objective To introduce a new semi-parametric method for non-inferiority analyses in three-arm trials w ith censored timeto-event data.Methods Three-arm non-inferiority trials w ith time-to-event endpoints could be analyzed based on the Cox proportional hazard model.Simulation tests w ere conducted to investigate the validity of the proposed method,and the R-language program of calculating required sample size w as given.Results When the hazard of censoring remained w ithin a certain value,the new method can control the type I error and has great pow er.Conclusion The recommended method in this paper could be used in the three-arm non-inferiority trials w ith censored time-to-event data.
出处 《中国卫生统计》 CSCD 北大核心 2013年第4期476-479,483,共5页 Chinese Journal of Health Statistics
基金 国家青年自然科学基金资助(项目编号:81102201)
关键词 临床试验 三臂非劣效 生存分析 COX模型 Clinical trial Three-arm Non-inferiority Cox Censored data
  • 相关文献

参考文献10

  • 1CCTS工作小组,夏结来.非劣效临床试验的统计学考虑[J].中国卫生统计,2012,29(2):270-274. 被引量:12
  • 2Fleming TR. Current issues in non-inferiority trials. Statistics in Medi- cine ,2008,27 ( 3 ) :317-332. 被引量:1
  • 3Pigeot I,Schafer J,Rohmel J,Hauschke D. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. STA- TISTICS IN MEDICINE ,2003,22:883-899. 被引量:1
  • 4Hauschke D, Kieser M, Diletti E, et al. Sample size determination for proving equivalence based on the ratio of two means for normally dis- tributed data. Statistics In Medicine, 1999,18 : 93-105. 被引量:1
  • 5Hasler M, Vonk R, Hothorn L. Assessing non-inferiority of a new treat- ment in a three-arm trial in the presence of heteroscedasticity. Statistics in Medcine ,2008,27:490-503. 被引量:1
  • 6Kieser M, Friede T. Planning and analysis of three-arm non-inferiority trials with binary endpoints. Statistics In Medicine ,2007,26:253-273. 被引量:1
  • 7Munzel U. Nonparametric non-inferiority analyses in the three-arm de- sign with active control and placebo. Statistics In Medicine, 2009,28: 3643 -3656. 被引量:1
  • 8Kombrink K, Munk A, Friede T. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time- to-event data. Statistics In Medicine, s2013,32 (18) :3055-3066. 被引量:1
  • 9Fleming TR, Lin DY. Survival Analysis in Clinical Trials:Past Develop- ments and Future Directions. Biometrics, 2000,56 ( 4 ) : 971-983. 被引量:1
  • 10Freitag G. Methods for assessing noninferiority with censored data. Bio- metrical Journal,2005,47 (1) :88-98. 被引量:1

二级参考文献15

  • 1Committee for Proprietary Medicinal Products(CPMP) (2000). Points to Consider on Switching Between Superiority and Non-Inferiority ht- tp ://www. emea. europa, eu/pdfs/human/ewp/048299en, pdf. 被引量:1
  • 2Siobhan ES, Scott SE. Bio-creep in non-inferiority clinical trials. Stat Med,2010,29 (27). 被引量:1
  • 3U. S. Department of Health and Human Services, Food and Drug Ad- ministration Center for Drug Evaluation and Research ( CDER ), Center for Biologics Evaluation and Research (CBER). Guidance for Industry Non-Inferiority Clinical Trials. 2010. http://www, fda. gov/Drugs/ GuidanceComplianceReeulatorylnformation/Guidances/default. htm. 被引量:1
  • 4Fleming TR. Current issues in non-inferiority trials. Stat Med, 2008,27 (3) :317-332. 被引量:1
  • 5Schumi J,Wittes JT. Through the looking glass:understanding non-infe- riority. Trials,2011,3(12) :106. 被引量:1
  • 6International Conference on Harmonization: Statistical Principles for Clinical Trials ( ICH E-9 ), Food and Drug Administration, DHHS, 1998. 被引量:1
  • 7International Conference on Harmonization:Choice of Control Group and Related Design and Conduct Issues in Clinical Trials (ICH E-10 ), Food and Drug Administration, DHHS, July ,2000. 被引量:1
  • 8Ng TH. Noninferiority Hypotheses and Choice of Noninferiority Mar- gin. Statistics in Medicine,2008,27:5392-5406. 被引量:1
  • 9Wang SJ,Hung HMJ. Assessment of Treatment Efficacy in Non-Inferi- ority Trials. Controlled Clinical Trials,2003,24:147-155. 被引量:1
  • 10Hung HMJ,Wang SJ, O' Neill RT. Non-Inferiority Trial. Wiley Ency- clopedia of Clinical Trials. Wiley, New York ,2008. 被引量:1

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部